ID
22302
Beschrijving
Study ID: 100151 Clinical Study ID: EGF100151 Study Title: A Phase III, Randomized, Open-label, Multicenter Study Comparing GW572016 and Capecitabine (XELODA) versus Capecitabine in Women with Refractory Advanced or Metastatic Breast Cancer Clinicaltrials.gov Identifier: NCT00078572 https://clinicaltrials.gov/ct2/show/NCT00078572 Procedure: Subject Status / Response Assessment, 6 Month Post-Therapy Follow-up Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: lapatinib Trade Name: Tyverb,Tykerb,Tycerb Study Indication: Breast Cancer; Neoplasms, Breast
Link
https://clinicaltrials.gov/ct2/show/NCT00078572
Trefwoorden
Versies (1)
- 29-05-17 29-05-17 -
Geüploaded op
29 mei 2017
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
XELODA and Lapatinib Advanced or Metastatic Breast Cancer 6 Month Post-Therapy Follow-up NCT00078572
XELODA and Lapatinib Advanced or Metastatic Breast Cancer 6 Month Post-Therapy Follow-up NCT00078572
Beschrijving
Response Assessment
Alias
- UMLS CUI-1
- C0521982
- UMLS CUI-2
- C0220825
- UMLS CUI-3
- C0678222
Beschrijving
If NO, complete the rest of this page.
Datatype
text
Alias
- UMLS CUI [1]
- C0242656
Beschrijving
lesion
Datatype
date
Alias
- UMLS CUI [1,1]
- C0011008
- UMLS CUI [1,2]
- C0221198
- UMLS CUI [1,3]
- C0220825
Beschrijving
Response assessment
Datatype
text
Alias
- UMLS CUI [1]
- C0521982
Beschrijving
method
Datatype
text
Alias
- UMLS CUI [1,1]
- C0871511
- UMLS CUI [1,2]
- C0221198
- UMLS CUI [1,3]
- C0220825
Beschrijving
If Symptomatic progression of cancer is checked, complete details below
Datatype
date
Alias
- UMLS CUI [1,1]
- C0011008
- UMLS CUI [1,2]
- C0178874
Beschrijving
Specify symptoms
Datatype
text
Alias
- UMLS CUI [1,1]
- C1457887
- UMLS CUI [1,2]
- C0178874
Similar models
XELODA and Lapatinib Advanced or Metastatic Breast Cancer 6 Month Post-Therapy Follow-up NCT00078572
C1522577 (UMLS CUI-2)
C0678222 (UMLS CUI-3)
C0920425 (UMLS CUI [1,2])
C0220825 (UMLS CUI-2)
C0678222 (UMLS CUI-3)
C0221198 (UMLS CUI [1,2])
C0220825 (UMLS CUI [1,3])
C0221198 (UMLS CUI [1,2])
C0220825 (UMLS CUI [1,3])
C0178874 (UMLS CUI [1,2])
C0178874 (UMLS CUI [1,2])